CKD-702

· National Cancer Center, Korea

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-702, covering 2023-03-01 to 2023-03-01. Get the full timeline:

Most recent: Clinical Trial Update: CKD-702 Plus Irinotecan in Gastric Cancer [Phase 2]